CorrespondenceFree Preview
Compliance with Results Reporting at ClinicalTrials.gov
To the Editor: The low compliance with ClinicalTrials.gov reporting requirements that Anderson et al. (March 12 issue)1 documented among clinical research sponsors should garner attention. As the research enterprise addresses this serious ethical breach, however, we must remember an equally binding obligation to share research findings with the clinical trial participants who make scientific advances possible.2Most participants (77%) are never informed of the trial's results, and 72% say that it is “very important” to address this issue.3 In a new report, the Institute of Medicine calls the sharing of results in understandable language a “matter of public transparency and . . .
Print Subscriber? Activate your online access.
